These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 10556133)
1. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Culpitt SV; Maziak W; Loukidis S; Nightingale JA; Matthews JL; Barnes PJ Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1635-9. PubMed ID: 10556133 [TBL] [Abstract][Full Text] [Related]
2. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615 [TBL] [Abstract][Full Text] [Related]
3. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Keatings VM; Jatakanon A; Worsdell YM; Barnes PJ Am J Respir Crit Care Med; 1997 Feb; 155(2):542-8. PubMed ID: 9032192 [TBL] [Abstract][Full Text] [Related]
4. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation]. Xin XF; Zhao M; Li ZL; Song Y; Shi Y Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998 [TBL] [Abstract][Full Text] [Related]
5. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Tsang KW; Ho PL; Lam WK; Ip MS; Chan KN; Ho CS; Ooi CC; Yuen KY Am J Respir Crit Care Med; 1998 Sep; 158(3):723-7. PubMed ID: 9730996 [TBL] [Abstract][Full Text] [Related]
6. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Loppow D; Schleiss MB; Kanniess F; Taube C; Jörres RA; Magnussen H Respir Med; 2001 Feb; 95(2):115-21. PubMed ID: 11217907 [TBL] [Abstract][Full Text] [Related]
7. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Barnes NC; Qiu YS; Pavord ID; Parker D; Davis PA; Zhu J; Johnson M; Thomson NC; Jeffery PK; Am J Respir Crit Care Med; 2006 Apr; 173(7):736-43. PubMed ID: 16424444 [TBL] [Abstract][Full Text] [Related]
8. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Llewellyn-Jones CG; Harris TA; Stockley RA Am J Respir Crit Care Med; 1996 Feb; 153(2):616-21. PubMed ID: 8564107 [TBL] [Abstract][Full Text] [Related]
9. Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis. Balfour-Lynn IM; Klein NJ; Dinwiddie R Arch Dis Child; 1997 Aug; 77(2):124-30. PubMed ID: 9301350 [TBL] [Abstract][Full Text] [Related]
10. Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease. Piccioni PD; Kramps JA; Rudolphus A; Bulgheroni A; Luisetti M Chest; 1992 Nov; 102(5):1470-6. PubMed ID: 1385052 [TBL] [Abstract][Full Text] [Related]
11. Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma. Vignola AM; Riccobono L; Profita M; Foresi A; Di Giorgi R; Guerrera D; Gjomarkaj M; Di Blasi P; Paggiaro PL Allergy; 2005 Dec; 60(12):1511-7. PubMed ID: 16266383 [TBL] [Abstract][Full Text] [Related]
12. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. in't Veen JC; Smits HH; Hiemstra PS; Zwinderman AE; Sterk PJ; Bel EH Am J Respir Crit Care Med; 1999 Jul; 160(1):93-9. PubMed ID: 10390385 [TBL] [Abstract][Full Text] [Related]
14. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Keatings VM; Collins PD; Scott DM; Barnes PJ Am J Respir Crit Care Med; 1996 Feb; 153(2):530-4. PubMed ID: 8564092 [TBL] [Abstract][Full Text] [Related]
15. Inhaled corticosteroids may reduce neutrophilic inflammation in patients with stable chronic obstructive pulmonary disease. Yildiz F; Kaur AC; Ilgazli A; Celikoglu M; Kaçar Ozkara S; Paksoy N; Ozkarakaş O Respiration; 2000; 67(1):71-6. PubMed ID: 10705266 [TBL] [Abstract][Full Text] [Related]
17. The interrelationship between markers of inflammation and oxidative stress in chronic obstructive pulmonary disease: modulation by inhaled steroids and antioxidant. Sadowska AM; van Overveld FJ; Górecka D; Zdral A; Filewska M; Demkow UA; Luyten C; Saenen E; Zielinski J; De Backer WA Respir Med; 2005 Feb; 99(2):241-9. PubMed ID: 15715193 [TBL] [Abstract][Full Text] [Related]
18. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Hattotuwa KL; Gizycki MJ; Ansari TW; Jeffery PK; Barnes NC Am J Respir Crit Care Med; 2002 Jun; 165(12):1592-6. PubMed ID: 12070058 [TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD. Perng DW; Tao CW; Su KC; Tsai CC; Liu LY; Lee YC Eur Respir J; 2009 Apr; 33(4):778-84. PubMed ID: 19129278 [TBL] [Abstract][Full Text] [Related]
20. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Brightling CE; McKenna S; Hargadon B; Birring S; Green R; Siva R; Berry M; Parker D; Monteiro W; Pavord ID; Bradding P Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]